ICER Recommends Major Price Reductions for New Sickle Cell Drugs
Sydney Otomancek2023-12-14T13:20:51-05:00February 3rd, 2020|Categories: Featured, Industry News|Tags: Adakveo, GBT, Healtheconomics.com, HEOR, ICER, market access, Novartis, Oxbryta, sickle cell disease|
The Institute for Clinical and Economic Review (ICER) in a draft report recommended significant price cuts for two sickle cell [...]
ICER Posts Draft Report on Sickle Cell Disease Therapies
Sydney Otomancek2023-12-14T13:21:05-05:00January 24th, 2020|Categories: Featured, Industry News|Tags: Adakveo, Endari, Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, market access, Oxbryta, sickle cell disease|
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 23, released a draft evidence report assessing treatments for [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!